Neuronetics (STIM) announced an exclusive three-year agreement with Elite DNA Behavioral Health, one of Florida’s largest and fastest-growing mental health networks, to become the sole provider of transcranial magnetic stimulation devices across Elite DNA’s 30+ locations. The collaboration also leverages the Company’s Greenbrook platform to provide Elite DNA with expanded fee-based, operational and patient-support services.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STIM: